Status:
RECRUITING
Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up
Lead Sponsor:
Waldemar Link GmbH & Co. KG
Conditions:
Osteoarthritis, Hip
Hip Osteoarthritis
Eligibility:
All Genders
18+ years
Brief Summary
The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results. The MobileLink hip prosthesis system is a CE marke...
Eligibility Criteria
Inclusion
- Implantation of a MobileLink acetabular cup system and a femoral stem manufactured by Waldemar Link
- Age ≥ 18 years
- Fully signed patient informed cons
Exclusion
- Revisions
- Body Mass Index (BMI) ≥ 40 kg/m²
- Patient who is foreseeable not able to understand the study and the study-related circumstances
- Patients who is foreseeable non-compliant to the treatment and the follow-ups
- Pregnant or breast-feeding women
- Prisoner
Key Trial Info
Start Date :
May 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2036
Estimated Enrollment :
520 Patients enrolled
Trial Details
Trial ID
NCT04688593
Start Date
May 4 2021
End Date
January 1 2036
Last Update
January 25 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Lubinus Stiftung
Kiel, Germany
2
NHS FIFE Victoria Hospital
Kirkcaldy, United Kingdom